Benzinga | May 6, 2021 04:47PM EDT

Assertio Therapeutics Q1 EPS $0.03 Beats $0.02 Estimate, Sales $26.84M Beat $24.33M Estimate; FY21 Net Product Sales $85M-$92M, Adj. EBITDA $34M-$40M

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.02 by 50 percent. This is a 70 percent decrease over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $26.84 million which beat the analyst consensus estimate of $24.33 million by 10.31 percent. This is a 28.31 percent increase over sales of $20.92 million the same period last year.